Opening book details…
About this Medicine article
OS6.4 NOA-16: A first-in-man multicenter phase I clinical trial of the German Neurooncology Working Group evaluating a mutation-specific peptide vaccine targeting IDH1R132H in patients with newly diagnosed malignant astrocytomas by Platten, M; Schilling, D; Bunse, L; Wick, A; Bunse, T; Riehl, D; Green, E; Sanghvi, K; Karapanagiotou-Schenkel, I; Harting, I; Sahm, F; Steinbach, J; Weyerbrock, A; Hense, J; Misch, M; Krex, D; Setvanovic, S; Tabatabai, G; von Deimling, A; Schmitt, M; Wick, W is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Platten, M; Schilling, D; Bunse, L; Wick, A; Bunse, T; Riehl, D; Green, E; Sanghvi, K; Karapanagiotou-Schenkel, I; Harting, I; Sahm, F; Steinbach, J; Weyerbrock, A; Hense, J; Misch, M; Krex, D; Setvanovic, S; Tabatabai, G; von Deimling, A; Schmitt, M; Wick, W
- Publisher
- Duke University Press; Oxford University Press; Oxford University Press (OUP) (ISSN 1522-8517)
- Published
- 2018
- Field
- Medicine (Health Sciences)